WuXi AppTec

Global Platform
One Vision

Our Vision

Every Drug Can Be Made
and Every Disease Can Be Treated

By Building an Open-access Platform with the Most Comprehensive Capabilities and Technologies in the Global Healthcare Industry

Our Values

Integrity & Dedication, Working Together & Sharing Success;
Doing the Right Thing, Doing It Right.

About Us

Enabling Innovation

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."

Services and Solutions

An Open Enabling Platform

Enabling more than 6,000 innovative customers from more than 30 Countries


Small Molecule Drug R&D and Manufacturing


Cell Therapy
and Gene Therapy


Drug R&D and Medical
Device Testing




Small Molecule Drug R&D and Manufacturing

Company Platform

Enabling Anyone, Any Company

To Become the Most Comprehensive Capability and Technology Platform in the Global Pharmaceutical and Healthcare Industry

WuXi Chemistry

Provides CRDMO services
for new drug development from discovery to commercial

WuXi Biology

A full spectrum of biology services and solutions
supporting stand-alone and integrated projects

WuXi Testing

Seamless drug and medical device testing services
from preclinical testing to clinical trials

WuXi Advanced Therapies

Global CTDMO
offering an integrated end-to-end solution to accelerate time to market for cell and gene therapies


The Latest News about WuXi AppTec

WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022

WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022

WuXi AppTec Reports Record Results in 2022

WuXi AppTec Named “Industry Mover” in S&P Global Sustainability Yearbook 2023

WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index

WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan


Welcome to

Our Team

Become Part of Creating a Better Life


The Latest Financial Reports, Announcements and Resources